PT  - JOURNAL ARTICLE
AU  - Anagnostopoulou, A.
AU  - Styliadis, C.
AU  - Kartsidis, P.
AU  - Romanopoulou, E.
AU  - Zilidou, V.
AU  - Karali, C.
AU  - Karagianni, M.
AU  - Klados, M.
AU  - Paraskevopoulos, E.
AU  - Bamidis, P. D.
TI  - Computerized physical and cognitive training improves functional architecture of the brain in Down Syndrome adults: a longitudinal network science EEG study
AID  - 10.1101/2020.05.28.20115709
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.28.20115709
4099  - http://medrxiv.org/content/early/2020/05/30/2020.05.28.20115709.short
4100  - http://medrxiv.org/content/early/2020/05/30/2020.05.28.20115709.full
AB  - Understanding the neuroplastic capacity of people with Down Syndrome (PwDS) can reveal the cause-effect relationship between aberrant brain organization and phenotypic characteristics. Non-invasive, neuroplasticity-triggering, training protocols, coupled with conventional evaluation methods, have reported promising results. However, the, so far, sparse neurophysiological and network science evidence, are also crucial in quantifying the efficacy of therapeutic interventions. Using electroencephalography (EEG)-acquired data, as well as connectivity and graph-theory approach, we aim to evaluate the effect of a non-invasive intervention on PwDS and track neuroplastic shifts in the DS brain network. 12 PwDS (6 males, average age 29) completed our 10-week protocol (combined physical and cognitive training). Prior to and after the intervention, they underwent eyes-open, resting-state EEG measurements in conjunction with psychosomatometric assessments. After the short-term training, the evaluations reflect increases in physical and cognitive capabilities, while the functional connectivity analysis showed a significant reorganization of the brain network of PwDS (i.e., calibration of connection intensity) and graph-theory analysis indicated significantly increased global and local efficiency and clustering and decreased path length between nodes. These differences delineate the effects of adaptational neuroplasticity, revealing a transition to a healthier, more efficient, and flexible network architecture, with improved integration and segregation abilities and a possible deceleration of neurodegenerative processes in the brain of PwDS. This trial is registered with http://ClinicalTrials.gov Identifier NCT04390321.Competing Interest StatementThere are potential conflicts of interest (other, not financial, outside the scope of the submitted work) for the author P. Bamidis in respect of PositScience and the Aristotle University of Thessaloniki. There is a co-marketing agreement between PositScience and the Aristotle University of Thessaloniki to exploit Brain HQ within the LLM Care self-funded initiative that emerged as the non-for-profit business exploitation of the Long Lasting Memories (LLM Project) (www.longlastingmemories.eu) originally funded by the ICT-CIP-PSP Program of the European Commission. Brain HQ now forms part of LLM Care, a technology transfer/self-funded initiative that emerged as the non-for-profit business exploitation of LLM. Additionally, FitForAll (FFA) has been developed in the Aristotle University of Thessaloniki during the Long Lasting Memories (LLM Project) (www.longlastingmemories.eu) originally funded by the ICT-CIP-PSP Program of the European Commission. It now forms part of LLM Care, a technology transfer/self-funded initiative that emerged as the non-for-profit business exploitation of LLM.Clinical TrialNCT04390321Funding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Bioethics Committee of the Medical School of Aristotle University of ThessalonikiAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data underlying the findings described in the manuscript will be fully available without restriction upon request